Cyclical etidronate in the management of osteoporosis in men

Reviews in Contemporary Pharmacotherapy

Volumn 9, Issue 4, 1998, Pages 261-266

  Francis, R M ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; ETIDRONIC ACID; FLUORIDE; TESTOSTERONE; VITAMIN D;

ALCOHOL ABUSE; BONE DENSITY; CORTICOSTEROID THERAPY; DRUG INTERMITTENT THERAPY; FRACTURE; HEALTH CARE COST; HIP FRACTURE; HUMAN; HYPOGONADISM; LUMBAR SPINE; MALE; MORBIDITY; MORTALITY; OSTEOPOROSIS; REVIEW; RISK; SEX RATIO; STOMACH SURGERY; VERTEBRA FRACTURE;

EID: 0031835353     PISSN: 09548602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Adachi JD, Bensen WG, Brown J et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997; 337: 382-387.
2. Anderson FH, Francis RM, Faulkner K. Androgen supplementation in eugonadal men with osteoporosis - effects of six months' treatment on bone mineral density and cardiovascular risk factors. Bone 1996; 18: 171-177.
3. Anderson FH, Francis RM, Bishop JC, Rawlings DA. Effect of intermittent cyclical disodium etidronate therapy on bone mineral density in men with vertebral fractures. Age Ageing 1997a; 26: 359-365.
4. Anderson FH, Francis RM, Peaston RT, Wastell HJ. Androgen supplementation in eugonadal men with osteoporosis - effects of six months' treatment on markers of bone formation and resorption. J Bone Miner Res 1997b; 12: 472-478.
5. Anderson FH, Francis RM, Selby PL, Cooper C. Sex hormones and osteoporosis in men. Calcif Tissue Int, in press.
6. Baillie SP, Davison CE, Johnson FJ, Francis RM. Pathogenesis of vertebral crush fractures in men. Age Ageing 1992; 21: 139-141.
7. Barlow DH. Report of the Advisory Group on Osteoporosis. London: Department of Health, 1994.
8. Black DM, Cummings SR, Genant HK, Nevitt MC, Palermo L, Browner W. Axial and appendicular bone density predict fractures in older women. J Bone Miner Res 1992; 7: 633-638.
9. Bonjour JP, Thientz G, Buchs B, Slosman D, Rizzoli R. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 1991; 73: 555-563.
10. Cooper C. Epidemiology and definition of osteoporosis. In: Compston JE, ed. Osteoporosis. New perspectives on causes, prevention and treatment. London: Royal College of Physicians of London, 1996: 1-10.
11. Dargie R, Gallagher S, Thompson G et al. Response of males with osteoporosis to intermittent cyclical therapy with etidronate/calcium over 3 to 5 years. In: Ring EFJ, Elvins DM, Bhalla AK, eds. Current reserch in osteoporosis and bone mineral measurement IV: 1996. London: British Institute of Radiology, 1996: 140.
12. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age and older. N Engl J Med 1997; 337: 670-676.
13. Devogelaer JP, de Cooman S, de Deuxchaisnes CN. Low bone mass in hypogonadal males. Effect of testosterone substitution therapy, a densito-metric study. Maturitas 1992; 15: 17-23.
14. Eastell R, Boyle IT, Compston J et al. Management of male osteoporosis: report of the UK Consensus Group. Q J Med 1998; 91: 71-92.
15. Finkelstein JS, Klibanski A, Neer RM et al. Increases in bone density during treatment of men with idiopathic hypogonadotrophic hypogonadism. J Clin Endocrinol Metab 1989; 69: 776-783.
16. Finkelstein JS, Neer RM, Biller BMK, Crawford JD, Klibanski A. Osteopenia in men with a history of delayed puberty. N Engl J Med 1992; 326: 600-604.
17. Foresta C, Busnardo B, Ruzza G, Zanatta G, Mioni R. Lower calcitonin levels in young hypogonadic men with osteoporosis. Horm Metab Res 1983; 15: 206-207.
18. Francis RM, Peacock M, Aaron JE et al. Osteoporosis in hypogonadal men: role of decreased plasma 1,25 dihydroxyvitamin D, calcium malabsorption and low bone formation. Bone 1986; 7: 261-268.
19. Geusens P, Vanhoof J, Nijs J, Joly J, Dequeker J, Smit S, Raus J. Heterogeneity of male osteoporosis: effect of cyclic treatment with etidronate and calcium. Osteoporosis Int 1996; 6 (Suppl 1): 285.
20. Heikinheimo RJ, Inkovaara JA, Harju EJ et al. Annual injection of Vitamin D and fractures of aged bones. Calcif Tissue Int 1992; 51: 105-110.
21. Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med 1996; 124: 400-406.
22. Lozano-Tonkin C, Garcia-Hernandez L, Gonzalez-Munoz MA. Treatment of osteoporosis (osteopenia) in adult men with disodium etidronate. Calcif Tissue Int 1994; 54: 451.
23. Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN. Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol 1996; 144: 255-263.
24. Orme SM, Simpson M, Stewart SP et al. Comparison of changes in bone mineral in idiopathic and secondary osteoporosis following therapy with cyclical disodium etidronate and high dose calcium supplementation. Clin Endocrinol 1994; 41: 245-250.
25. Orwoll ES, Oviatt SK, McClung MR, Deftos LJ, Sexton G. The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. Ann Int Med 1990; 112: 29-34.
26. Pitt P, Li F, Bloom B et al. A double-blind placebo controlled study of intermittent cyclical etidronate on bone mineral density in patients on long-term corticosteroid treatment. Bone 1997; 20,4S: P232.
27. Pitt P, Li F, Todd P, Webber DM, Pack S, Moniz C. A double-bind placebo-controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term corticosteroid treatment. Thorax 1998, in press.
28. Poor G, Jacobsen SJ, Melton LJ. Mortality after hip fracture. Facts Res Gerontol 1994; 7: 91-109.
29. Poor G, Atkinson EJ, Lewallen DG, O'Fallon WM, Melton LJ. Age-related hip fracture in men: clinical spectrum and short-term outcome. Osteoporosis Int 1995a; 5: 419-426.
30. Poor G, Atkinson EJ, O'Fallon WM, Melton LJ. Predictors of hip fractures in elderly men. J Bone Miner Res 1995b; 10: 1900-1907.
31. Reid IR, Wattie DJ, Evans MC, Stapleton JP. Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 1996; 156: 1173-1177.
32. Ringe JD, Kipshoven C, Rovati L, Setnikar I. Therapy of idiopathic male osteoporosis: a 3-year study with calcium and low dose intermittent monofluorophosphate: In: Papapoulos SE, Lips P, Pols HAP, Johnston CC, Delmas PD, eds. Osteoporosis '96. Amsterdam: Elsevier, 1996: 383-390.
33. Ross PD, Davis JW, Epstein RS, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991; 114: 919-923.
34. Scane AC, Francis RM. Risk factors for osteoporosis in men. Clin Endocrinol 1993; 38: 15-16.
35. Scane AC, Francis RM, Johnson FJ, Davison CE. The effects of testosterone treatment in eugonadal men with osteoporosis. In: Ring EFJ, ed. Current research in osteoporosis and bone mineral measurement II: 1992. London: British Institute of Radiology, 1992: 54.
36. Scane AC, Sutcliffe AM, Francis RM. The sequelae of vertebral crush fractures in men. Osteoporosis Int 1994; 4: 89-92.
37. Scane AC, Sutcliffe AM, Francis MJD, Rawlings D, Chapple CL, Francis RM. Case-control study of vertebral fractures in men. Age Ageing 1996; 25 (Suppl 2): P6.
38. Seeman E, Melton LJ, O'Fallon WM, Riggs BL. Risk factors for spinal osteoporosis in men. Am J Med 1983; 75: 977-983.
39. Selby PL, Rehman MT, Economou G et al. Etidronate in male osteoporosis: evidence for a site-specific action. Proceedings of the Fourth International Symposium on Osteoporosis. Hong Kong, 1993: 197-198.
40. Stanley HL, Schmitt BP, Poses RM, Deiss WP. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Am Geriatr Soc 1991; 39: 766-771.
41. van Staa TP, Abenhaim L, Cooper C. Use of cyclical etidronate and prevention of non-vertebral fractures. Br J Rheumatol 1998; 36: 1-8.
42. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. Geneva: World Health Organization, 1994.